Impact of asundexian on a panel of coagulation assays
Despite this study including a comprehensive panel of coagulation assays, asundexian may still affect other coagulation assays not assessed here. Further investigations in patients treated with asundexian are therefore warranted.
Authors
- François Mullier (ORCID: https://orcid.org/0000-0001-6947-6099)
- Julien Favresse (ORCID: https://orcid.org/0000-0002-9805-049X)
- Marie Didembourg (ORCID: https://orcid.org/0000-0002-9170-0314)
- Laure Morimont (ORCID: https://orcid.org/0000-0001-9195-304X)
- Jean‐Michel Dogné (ORCID: https://orcid.org/0000-0003-2107-1804)
- Laurent Jamart
- Jonathan Douxfils (ORCID: https://orcid.org/0000-0002-7644-5298)
- Michaël Hardy (ORCID: https://orcid.org/0000-0001-6701-9417)
- Aurélien Lebreton (ORCID: https://orcid.org/0000-0002-1650-0427)
- Julie Vassart (ORCID: https://orcid.org/0009-0004-2512-7494)
- Clotilde Brisbois
- Diane Bangoup Ndzatou
- Fabian Demeure
Institutions
- University of Namur (BE)
- CHU Dinant Godinne UCL Namur (BE)
- Comagine Health (US)
- Centre Hospitalier Régional de Namur (BE)
- Clinique Saint-Joseph (BE)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- UCLouvain (BE)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.rpth.2025.102950
- Primary Topic
- Hemodynamic Monitoring and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00